nodes	percent_of_prediction	percent_of_DWPC	metapath
Ethotoin—Non-Hodgkin's lymphoma—Melphalan—ovarian cancer	0.0612	0.069	CcSEcCtD
Ethotoin—Lymphoma—Melphalan—ovarian cancer	0.0612	0.069	CcSEcCtD
Ethotoin—Ataxia—Altretamine—ovarian cancer	0.0471	0.0531	CcSEcCtD
Ethotoin—Systemic lupus erythematosus—Paclitaxel—ovarian cancer	0.0227	0.0256	CcSEcCtD
Ethotoin—Numbness—Vinorelbine—ovarian cancer	0.0225	0.0254	CcSEcCtD
Ethotoin—Sensory loss—Vinorelbine—ovarian cancer	0.0216	0.0243	CcSEcCtD
Ethotoin—Fatigue—Altretamine—ovarian cancer	0.0212	0.0239	CcSEcCtD
Ethotoin—Lymphadenopathy—Chlorambucil—ovarian cancer	0.0209	0.0235	CcSEcCtD
Ethotoin—Systemic lupus erythematosus—Docetaxel—ovarian cancer	0.0192	0.0217	CcSEcCtD
Ethotoin—Asthenia—Altretamine—ovarian cancer	0.0177	0.0199	CcSEcCtD
Ethotoin—Ataxia—Chlorambucil—ovarian cancer	0.0167	0.0189	CcSEcCtD
Ethotoin—Dizziness—Altretamine—ovarian cancer	0.0163	0.0184	CcSEcCtD
Ethotoin—Vomiting—Altretamine—ovarian cancer	0.0157	0.0177	CcSEcCtD
Ethotoin—Nausea—Altretamine—ovarian cancer	0.0146	0.0165	CcSEcCtD
Ethotoin—Sensory loss—Paclitaxel—ovarian cancer	0.0145	0.0164	CcSEcCtD
Ethotoin—Stevens-Johnson syndrome—Chlorambucil—ovarian cancer	0.0136	0.0153	CcSEcCtD
Ethotoin—Body temperature increased—Carboplatin—ovarian cancer	0.0134	0.0152	CcSEcCtD
Ethotoin—Erythema multiforme—Chlorambucil—ovarian cancer	0.0116	0.0131	CcSEcCtD
Ethotoin—Hypoaesthesia—Topotecan—ovarian cancer	0.0109	0.0123	CcSEcCtD
Ethotoin—SCN7A—myometrium—ovarian cancer	0.0103	0.142	CbGeAlD
Ethotoin—Nystagmus—Epirubicin—ovarian cancer	0.0101	0.0113	CcSEcCtD
Ethotoin—Hypoaesthesia—Vinorelbine—ovarian cancer	0.00933	0.0105	CcSEcCtD
Ethotoin—Nystagmus—Doxorubicin—ovarian cancer	0.0093	0.0105	CcSEcCtD
Ethotoin—Ataxia—Paclitaxel—ovarian cancer	0.00857	0.00967	CcSEcCtD
Ethotoin—Chest pain—Topotecan—ovarian cancer	0.00812	0.00916	CcSEcCtD
Ethotoin—Chest pain—Melphalan—ovarian cancer	0.00795	0.00897	CcSEcCtD
Ethotoin—Fatigue—Chlorambucil—ovarian cancer	0.00754	0.00851	CcSEcCtD
Ethotoin—Ataxia—Docetaxel—ovarian cancer	0.00727	0.0082	CcSEcCtD
Ethotoin—Stevens-Johnson syndrome—Paclitaxel—ovarian cancer	0.00697	0.00786	CcSEcCtD
Ethotoin—Chest pain—Vinorelbine—ovarian cancer	0.00695	0.00784	CcSEcCtD
Ethotoin—Body temperature increased—Chlorambucil—ovarian cancer	0.00692	0.0078	CcSEcCtD
Ethotoin—Fatigue—Topotecan—ovarian cancer	0.00671	0.00757	CcSEcCtD
Ethotoin—Fatigue—Melphalan—ovarian cancer	0.00657	0.00742	CcSEcCtD
Ethotoin—Asthenia—Chlorambucil—ovarian cancer	0.00628	0.00708	CcSEcCtD
Ethotoin—Hypoaesthesia—Paclitaxel—ovarian cancer	0.00628	0.00708	CcSEcCtD
Ethotoin—Body temperature increased—Topotecan—ovarian cancer	0.00616	0.00695	CcSEcCtD
Ethotoin—Lymphadenopathy—Epirubicin—ovarian cancer	0.00611	0.00689	CcSEcCtD
Ethotoin—SCN7A—female reproductive system—ovarian cancer	0.00599	0.0826	CbGeAlD
Ethotoin—Diarrhoea—Chlorambucil—ovarian cancer	0.00599	0.00675	CcSEcCtD
Ethotoin—Erythema multiforme—Paclitaxel—ovarian cancer	0.00596	0.00673	CcSEcCtD
Ethotoin—Stevens-Johnson syndrome—Docetaxel—ovarian cancer	0.0059	0.00666	CcSEcCtD
Ethotoin—Fatigue—Vinorelbine—ovarian cancer	0.00574	0.00648	CcSEcCtD
Ethotoin—Lymphadenopathy—Doxorubicin—ovarian cancer	0.00565	0.00638	CcSEcCtD
Ethotoin—Asthenia—Topotecan—ovarian cancer	0.00559	0.0063	CcSEcCtD
Ethotoin—Vomiting—Chlorambucil—ovarian cancer	0.00556	0.00627	CcSEcCtD
Ethotoin—Asthenia—Melphalan—ovarian cancer	0.00547	0.00617	CcSEcCtD
Ethotoin—SCN7A—female gonad—ovarian cancer	0.00545	0.0752	CbGeAlD
Ethotoin—Diarrhoea—Topotecan—ovarian cancer	0.00533	0.00601	CcSEcCtD
Ethotoin—Hypoaesthesia—Docetaxel—ovarian cancer	0.00532	0.006	CcSEcCtD
Ethotoin—Body temperature increased—Vinorelbine—ovarian cancer	0.00527	0.00594	CcSEcCtD
Ethotoin—Diarrhoea—Melphalan—ovarian cancer	0.00522	0.00589	CcSEcCtD
Ethotoin—Diplopia—Epirubicin—ovarian cancer	0.00521	0.00588	CcSEcCtD
Ethotoin—Nausea—Chlorambucil—ovarian cancer	0.0052	0.00586	CcSEcCtD
Ethotoin—Dizziness—Topotecan—ovarian cancer	0.00515	0.00581	CcSEcCtD
Ethotoin—Erythema multiforme—Docetaxel—ovarian cancer	0.00505	0.0057	CcSEcCtD
Ethotoin—Vomiting—Topotecan—ovarian cancer	0.00495	0.00559	CcSEcCtD
Ethotoin—Rash—Topotecan—ovarian cancer	0.00491	0.00554	CcSEcCtD
Ethotoin—Dermatitis—Topotecan—ovarian cancer	0.00491	0.00553	CcSEcCtD
Ethotoin—Ataxia—Epirubicin—ovarian cancer	0.0049	0.00553	CcSEcCtD
Ethotoin—Headache—Topotecan—ovarian cancer	0.00488	0.0055	CcSEcCtD
Ethotoin—Vomiting—Melphalan—ovarian cancer	0.00485	0.00547	CcSEcCtD
Ethotoin—SCN7A—testis—ovarian cancer	0.00483	0.0667	CbGeAlD
Ethotoin—Diplopia—Doxorubicin—ovarian cancer	0.00482	0.00544	CcSEcCtD
Ethotoin—Rash—Melphalan—ovarian cancer	0.00481	0.00542	CcSEcCtD
Ethotoin—Dermatitis—Melphalan—ovarian cancer	0.0048	0.00542	CcSEcCtD
Ethotoin—Asthenia—Vinorelbine—ovarian cancer	0.00478	0.00539	CcSEcCtD
Ethotoin—Chest pain—Paclitaxel—ovarian cancer	0.00467	0.00527	CcSEcCtD
Ethotoin—Nausea—Topotecan—ovarian cancer	0.00463	0.00522	CcSEcCtD
Ethotoin—Diarrhoea—Vinorelbine—ovarian cancer	0.00456	0.00514	CcSEcCtD
Ethotoin—Ataxia—Doxorubicin—ovarian cancer	0.00454	0.00512	CcSEcCtD
Ethotoin—Nausea—Melphalan—ovarian cancer	0.00453	0.00511	CcSEcCtD
Ethotoin—Dizziness—Vinorelbine—ovarian cancer	0.00441	0.00497	CcSEcCtD
Ethotoin—SCN8A—testis—ovarian cancer	0.00431	0.0594	CbGeAlD
Ethotoin—Vomiting—Vinorelbine—ovarian cancer	0.00424	0.00478	CcSEcCtD
Ethotoin—Rash—Vinorelbine—ovarian cancer	0.0042	0.00474	CcSEcCtD
Ethotoin—Dermatitis—Vinorelbine—ovarian cancer	0.0042	0.00473	CcSEcCtD
Ethotoin—Headache—Vinorelbine—ovarian cancer	0.00417	0.00471	CcSEcCtD
Ethotoin—SCN3A—decidua—ovarian cancer	0.00414	0.0571	CbGeAlD
Ethotoin—Insomnia—Paclitaxel—ovarian cancer	0.00405	0.00457	CcSEcCtD
Ethotoin—Stevens-Johnson syndrome—Epirubicin—ovarian cancer	0.00398	0.00449	CcSEcCtD
Ethotoin—Chest pain—Docetaxel—ovarian cancer	0.00396	0.00447	CcSEcCtD
Ethotoin—Nausea—Vinorelbine—ovarian cancer	0.00396	0.00446	CcSEcCtD
Ethotoin—Fatigue—Paclitaxel—ovarian cancer	0.00386	0.00436	CcSEcCtD
Ethotoin—SCN9A—testis—ovarian cancer	0.00379	0.0522	CbGeAlD
Ethotoin—Stevens-Johnson syndrome—Doxorubicin—ovarian cancer	0.00368	0.00416	CcSEcCtD
Ethotoin—Hypoaesthesia—Epirubicin—ovarian cancer	0.00359	0.00405	CcSEcCtD
Ethotoin—Body temperature increased—Paclitaxel—ovarian cancer	0.00354	0.004	CcSEcCtD
Ethotoin—SCN7A—lymph node—ovarian cancer	0.0035	0.0483	CbGeAlD
Ethotoin—Insomnia—Docetaxel—ovarian cancer	0.00344	0.00388	CcSEcCtD
Ethotoin—Erythema multiforme—Epirubicin—ovarian cancer	0.00341	0.00385	CcSEcCtD
Ethotoin—SCN4A—testis—ovarian cancer	0.00338	0.0466	CbGeAlD
Ethotoin—SCN2A—vagina—ovarian cancer	0.00335	0.0462	CbGeAlD
Ethotoin—Hypoaesthesia—Doxorubicin—ovarian cancer	0.00332	0.00375	CcSEcCtD
Ethotoin—Fatigue—Docetaxel—ovarian cancer	0.00327	0.00369	CcSEcCtD
Ethotoin—SCN3A—female reproductive system—ovarian cancer	0.00326	0.0449	CbGeAlD
Ethotoin—Asthenia—Paclitaxel—ovarian cancer	0.00322	0.00363	CcSEcCtD
Ethotoin—Erythema multiforme—Doxorubicin—ovarian cancer	0.00315	0.00356	CcSEcCtD
Ethotoin—SCN3A—bone marrow—ovarian cancer	0.00307	0.0424	CbGeAlD
Ethotoin—Diarrhoea—Paclitaxel—ovarian cancer	0.00307	0.00346	CcSEcCtD
Ethotoin—Body temperature increased—Docetaxel—ovarian cancer	0.003	0.00339	CcSEcCtD
Ethotoin—Dizziness—Paclitaxel—ovarian cancer	0.00296	0.00334	CcSEcCtD
Ethotoin—SCN3A—vagina—ovarian cancer	0.00294	0.0406	CbGeAlD
Ethotoin—SCN5A—vagina—ovarian cancer	0.00294	0.0405	CbGeAlD
Ethotoin—Vomiting—Paclitaxel—ovarian cancer	0.00285	0.00321	CcSEcCtD
Ethotoin—Rash—Paclitaxel—ovarian cancer	0.00283	0.00319	CcSEcCtD
Ethotoin—Dermatitis—Paclitaxel—ovarian cancer	0.00282	0.00318	CcSEcCtD
Ethotoin—Headache—Paclitaxel—ovarian cancer	0.00281	0.00317	CcSEcCtD
Ethotoin—SCN9A—lymph node—ovarian cancer	0.00274	0.0379	CbGeAlD
Ethotoin—Asthenia—Docetaxel—ovarian cancer	0.00273	0.00307	CcSEcCtD
Ethotoin—Chest pain—Epirubicin—ovarian cancer	0.00267	0.00301	CcSEcCtD
Ethotoin—Nausea—Paclitaxel—ovarian cancer	0.00266	0.003	CcSEcCtD
Ethotoin—SCN3A—testis—ovarian cancer	0.00263	0.0362	CbGeAlD
Ethotoin—Diarrhoea—Docetaxel—ovarian cancer	0.0026	0.00293	CcSEcCtD
Ethotoin—Dizziness—Docetaxel—ovarian cancer	0.00251	0.00283	CcSEcCtD
Ethotoin—Chest pain—Doxorubicin—ovarian cancer	0.00247	0.00279	CcSEcCtD
Ethotoin—Vomiting—Docetaxel—ovarian cancer	0.00241	0.00272	CcSEcCtD
Ethotoin—Rash—Docetaxel—ovarian cancer	0.00239	0.0027	CcSEcCtD
Ethotoin—Dermatitis—Docetaxel—ovarian cancer	0.00239	0.0027	CcSEcCtD
Ethotoin—Headache—Docetaxel—ovarian cancer	0.00238	0.00268	CcSEcCtD
Ethotoin—Insomnia—Epirubicin—ovarian cancer	0.00232	0.00261	CcSEcCtD
Ethotoin—Nausea—Docetaxel—ovarian cancer	0.00226	0.00255	CcSEcCtD
Ethotoin—Fatigue—Epirubicin—ovarian cancer	0.00221	0.00249	CcSEcCtD
Ethotoin—Insomnia—Doxorubicin—ovarian cancer	0.00214	0.00242	CcSEcCtD
Ethotoin—SCN10A—lymph node—ovarian cancer	0.00209	0.0288	CbGeAlD
Ethotoin—Fatigue—Doxorubicin—ovarian cancer	0.00204	0.00231	CcSEcCtD
Ethotoin—Body temperature increased—Epirubicin—ovarian cancer	0.00203	0.00228	CcSEcCtD
Ethotoin—SCN3A—lymph node—ovarian cancer	0.0019	0.0263	CbGeAlD
Ethotoin—CYP2C19—vagina—ovarian cancer	0.00189	0.0261	CbGeAlD
Ethotoin—Body temperature increased—Doxorubicin—ovarian cancer	0.00187	0.00211	CcSEcCtD
Ethotoin—Asthenia—Epirubicin—ovarian cancer	0.00184	0.00207	CcSEcCtD
Ethotoin—Diarrhoea—Epirubicin—ovarian cancer	0.00175	0.00198	CcSEcCtD
Ethotoin—Asthenia—Doxorubicin—ovarian cancer	0.0017	0.00192	CcSEcCtD
Ethotoin—Dizziness—Epirubicin—ovarian cancer	0.00169	0.00191	CcSEcCtD
Ethotoin—Vomiting—Epirubicin—ovarian cancer	0.00163	0.00184	CcSEcCtD
Ethotoin—Diarrhoea—Doxorubicin—ovarian cancer	0.00162	0.00183	CcSEcCtD
Ethotoin—Rash—Epirubicin—ovarian cancer	0.00162	0.00182	CcSEcCtD
Ethotoin—Dermatitis—Epirubicin—ovarian cancer	0.00161	0.00182	CcSEcCtD
Ethotoin—Headache—Epirubicin—ovarian cancer	0.0016	0.00181	CcSEcCtD
Ethotoin—Dizziness—Doxorubicin—ovarian cancer	0.00157	0.00177	CcSEcCtD
Ethotoin—Nausea—Epirubicin—ovarian cancer	0.00152	0.00172	CcSEcCtD
Ethotoin—Vomiting—Doxorubicin—ovarian cancer	0.00151	0.0017	CcSEcCtD
Ethotoin—Rash—Doxorubicin—ovarian cancer	0.00149	0.00169	CcSEcCtD
Ethotoin—Dermatitis—Doxorubicin—ovarian cancer	0.00149	0.00168	CcSEcCtD
Ethotoin—Headache—Doxorubicin—ovarian cancer	0.00149	0.00168	CcSEcCtD
Ethotoin—Nausea—Doxorubicin—ovarian cancer	0.00141	0.00159	CcSEcCtD
Ethotoin—SCN8A—Developmental Biology—ERBB2—ovarian cancer	9.56e-05	0.00233	CbGpPWpGaD
Ethotoin—SCN2A—Developmental Biology—IL6ST—ovarian cancer	9.52e-05	0.00232	CbGpPWpGaD
Ethotoin—SCN4A—Developmental Biology—IL6ST—ovarian cancer	9.52e-05	0.00232	CbGpPWpGaD
Ethotoin—SCN1A—Developmental Biology—MET—ovarian cancer	9.37e-05	0.00228	CbGpPWpGaD
Ethotoin—SCN10A—Developmental Biology—MET—ovarian cancer	9.37e-05	0.00228	CbGpPWpGaD
Ethotoin—SCN5A—SIDS Susceptibility Pathways—VEGFA—ovarian cancer	9.33e-05	0.00227	CbGpPWpGaD
Ethotoin—SCN9A—Axon guidance—MMP9—ovarian cancer	9.29e-05	0.00226	CbGpPWpGaD
Ethotoin—SCN8A—Axon guidance—MAPK1—ovarian cancer	9.28e-05	0.00226	CbGpPWpGaD
Ethotoin—SCN8A—Axon guidance—EGFR—ovarian cancer	9.28e-05	0.00226	CbGpPWpGaD
Ethotoin—SCN5A—Axon guidance—MET—ovarian cancer	9.23e-05	0.00225	CbGpPWpGaD
Ethotoin—SCN10A—Developmental Biology—IL6ST—ovarian cancer	9.18e-05	0.00224	CbGpPWpGaD
Ethotoin—SCN1A—Developmental Biology—IL6ST—ovarian cancer	9.18e-05	0.00224	CbGpPWpGaD
Ethotoin—SCN7A—Axon guidance—HRAS—ovarian cancer	9.14e-05	0.00223	CbGpPWpGaD
Ethotoin—SCN11A—Developmental Biology—CTNNB1—ovarian cancer	9.14e-05	0.00223	CbGpPWpGaD
Ethotoin—SCN5A—Axon guidance—IL6ST—ovarian cancer	9.04e-05	0.0022	CbGpPWpGaD
Ethotoin—SCN7A—Developmental Biology—VEGFA—ovarian cancer	9.03e-05	0.0022	CbGpPWpGaD
Ethotoin—SCN11A—Developmental Biology—MMP9—ovarian cancer	8.96e-05	0.00218	CbGpPWpGaD
Ethotoin—SCN7A—Developmental Biology—STAT3—ovarian cancer	8.94e-05	0.00218	CbGpPWpGaD
Ethotoin—SCN7A—Developmental Biology—NRAS—ovarian cancer	8.92e-05	0.00217	CbGpPWpGaD
Ethotoin—SCN3A—Axon guidance—MMP9—ovarian cancer	8.89e-05	0.00216	CbGpPWpGaD
Ethotoin—SCN9A—Developmental Biology—MMP2—ovarian cancer	8.82e-05	0.00215	CbGpPWpGaD
Ethotoin—SCN8A—Axon guidance—KRAS—ovarian cancer	8.77e-05	0.00214	CbGpPWpGaD
Ethotoin—SCN7A—Axon guidance—IL6—ovarian cancer	8.75e-05	0.00213	CbGpPWpGaD
Ethotoin—SCN7A—Developmental Biology—MAPK3—ovarian cancer	8.54e-05	0.00208	CbGpPWpGaD
Ethotoin—SCN4A—Axon guidance—MMP9—ovarian cancer	8.54e-05	0.00208	CbGpPWpGaD
Ethotoin—SCN2A—Axon guidance—MMP9—ovarian cancer	8.54e-05	0.00208	CbGpPWpGaD
Ethotoin—SCN3A—Developmental Biology—MMP2—ovarian cancer	8.44e-05	0.00205	CbGpPWpGaD
Ethotoin—SCN8A—Developmental Biology—CTNNB1—ovarian cancer	8.36e-05	0.00204	CbGpPWpGaD
Ethotoin—SCN9A—Axon guidance—VEGFA—ovarian cancer	8.34e-05	0.00203	CbGpPWpGaD
Ethotoin—SCN9A—Axon guidance—NRAS—ovarian cancer	8.24e-05	0.00201	CbGpPWpGaD
Ethotoin—SCN10A—Axon guidance—MMP9—ovarian cancer	8.23e-05	0.002	CbGpPWpGaD
Ethotoin—SCN1A—Axon guidance—MMP9—ovarian cancer	8.23e-05	0.002	CbGpPWpGaD
Ethotoin—CYP2C19—Biological oxidations—CYP1B1—ovarian cancer	8.23e-05	0.002	CbGpPWpGaD
Ethotoin—SCN8A—Developmental Biology—MMP9—ovarian cancer	8.2e-05	0.002	CbGpPWpGaD
Ethotoin—SCN11A—Axon guidance—HRAS—ovarian cancer	8.15e-05	0.00198	CbGpPWpGaD
Ethotoin—SCN7A—Developmental Biology—MAPK1—ovarian cancer	8.13e-05	0.00198	CbGpPWpGaD
Ethotoin—SCN7A—Developmental Biology—EGFR—ovarian cancer	8.13e-05	0.00198	CbGpPWpGaD
Ethotoin—CYP2C19—Metapathway biotransformation—CYP1B1—ovarian cancer	8.11e-05	0.00198	CbGpPWpGaD
Ethotoin—SCN4A—Developmental Biology—MMP2—ovarian cancer	8.11e-05	0.00197	CbGpPWpGaD
Ethotoin—SCN2A—Developmental Biology—MMP2—ovarian cancer	8.11e-05	0.00197	CbGpPWpGaD
Ethotoin—SCN11A—Developmental Biology—VEGFA—ovarian cancer	8.05e-05	0.00196	CbGpPWpGaD
Ethotoin—SCN3A—Axon guidance—VEGFA—ovarian cancer	7.98e-05	0.00194	CbGpPWpGaD
Ethotoin—SCN11A—Developmental Biology—STAT3—ovarian cancer	7.97e-05	0.00194	CbGpPWpGaD
Ethotoin—SCN11A—Developmental Biology—NRAS—ovarian cancer	7.95e-05	0.00194	CbGpPWpGaD
Ethotoin—SCN9A—Axon guidance—MAPK3—ovarian cancer	7.89e-05	0.00192	CbGpPWpGaD
Ethotoin—SCN3A—Axon guidance—NRAS—ovarian cancer	7.88e-05	0.00192	CbGpPWpGaD
Ethotoin—SCN1A—Developmental Biology—MMP2—ovarian cancer	7.82e-05	0.0019	CbGpPWpGaD
Ethotoin—SCN10A—Developmental Biology—MMP2—ovarian cancer	7.82e-05	0.0019	CbGpPWpGaD
Ethotoin—SCN11A—Axon guidance—IL6—ovarian cancer	7.8e-05	0.0019	CbGpPWpGaD
Ethotoin—SCN9A—Developmental Biology—ERBB2—ovarian cancer	7.73e-05	0.00188	CbGpPWpGaD
Ethotoin—SCN5A—Axon guidance—MMP2—ovarian cancer	7.7e-05	0.00188	CbGpPWpGaD
Ethotoin—SCN7A—Developmental Biology—KRAS—ovarian cancer	7.68e-05	0.00187	CbGpPWpGaD
Ethotoin—SCN2A—Axon guidance—VEGFA—ovarian cancer	7.67e-05	0.00187	CbGpPWpGaD
Ethotoin—SCN4A—Axon guidance—VEGFA—ovarian cancer	7.67e-05	0.00187	CbGpPWpGaD
Ethotoin—SCN11A—Developmental Biology—MAPK3—ovarian cancer	7.61e-05	0.00185	CbGpPWpGaD
Ethotoin—SCN2A—Axon guidance—NRAS—ovarian cancer	7.57e-05	0.00184	CbGpPWpGaD
Ethotoin—SCN4A—Axon guidance—NRAS—ovarian cancer	7.57e-05	0.00184	CbGpPWpGaD
Ethotoin—SCN3A—Axon guidance—MAPK3—ovarian cancer	7.55e-05	0.00184	CbGpPWpGaD
Ethotoin—SCN9A—Axon guidance—MAPK1—ovarian cancer	7.51e-05	0.00183	CbGpPWpGaD
Ethotoin—SCN9A—Axon guidance—EGFR—ovarian cancer	7.51e-05	0.00183	CbGpPWpGaD
Ethotoin—SCN8A—Axon guidance—HRAS—ovarian cancer	7.45e-05	0.00182	CbGpPWpGaD
Ethotoin—SCN3A—Developmental Biology—ERBB2—ovarian cancer	7.39e-05	0.0018	CbGpPWpGaD
Ethotoin—SCN10A—Axon guidance—VEGFA—ovarian cancer	7.39e-05	0.0018	CbGpPWpGaD
Ethotoin—SCN1A—Axon guidance—VEGFA—ovarian cancer	7.39e-05	0.0018	CbGpPWpGaD
Ethotoin—SCN8A—Developmental Biology—VEGFA—ovarian cancer	7.36e-05	0.00179	CbGpPWpGaD
Ethotoin—SCN10A—Axon guidance—NRAS—ovarian cancer	7.3e-05	0.00178	CbGpPWpGaD
Ethotoin—SCN1A—Axon guidance—NRAS—ovarian cancer	7.3e-05	0.00178	CbGpPWpGaD
Ethotoin—SCN8A—Developmental Biology—STAT3—ovarian cancer	7.29e-05	0.00177	CbGpPWpGaD
Ethotoin—SCN8A—Developmental Biology—NRAS—ovarian cancer	7.27e-05	0.00177	CbGpPWpGaD
Ethotoin—SCN4A—Axon guidance—MAPK3—ovarian cancer	7.25e-05	0.00177	CbGpPWpGaD
Ethotoin—SCN2A—Axon guidance—MAPK3—ovarian cancer	7.25e-05	0.00177	CbGpPWpGaD
Ethotoin—SCN11A—Developmental Biology—MAPK1—ovarian cancer	7.24e-05	0.00176	CbGpPWpGaD
Ethotoin—SCN11A—Developmental Biology—EGFR—ovarian cancer	7.24e-05	0.00176	CbGpPWpGaD
Ethotoin—SCN3A—Axon guidance—MAPK1—ovarian cancer	7.18e-05	0.00175	CbGpPWpGaD
Ethotoin—SCN3A—Axon guidance—EGFR—ovarian cancer	7.18e-05	0.00175	CbGpPWpGaD
Ethotoin—SCN8A—Axon guidance—IL6—ovarian cancer	7.13e-05	0.00174	CbGpPWpGaD
Ethotoin—SCN2A—Developmental Biology—ERBB2—ovarian cancer	7.1e-05	0.00173	CbGpPWpGaD
Ethotoin—SCN4A—Developmental Biology—ERBB2—ovarian cancer	7.1e-05	0.00173	CbGpPWpGaD
Ethotoin—SCN9A—Axon guidance—KRAS—ovarian cancer	7.09e-05	0.00173	CbGpPWpGaD
Ethotoin—SCN10A—Axon guidance—MAPK3—ovarian cancer	6.99e-05	0.0017	CbGpPWpGaD
Ethotoin—SCN1A—Axon guidance—MAPK3—ovarian cancer	6.99e-05	0.0017	CbGpPWpGaD
Ethotoin—SCN8A—Developmental Biology—MAPK3—ovarian cancer	6.96e-05	0.0017	CbGpPWpGaD
Ethotoin—SCN4A—Axon guidance—MAPK1—ovarian cancer	6.9e-05	0.00168	CbGpPWpGaD
Ethotoin—SCN2A—Axon guidance—MAPK1—ovarian cancer	6.9e-05	0.00168	CbGpPWpGaD
Ethotoin—SCN2A—Axon guidance—EGFR—ovarian cancer	6.9e-05	0.00168	CbGpPWpGaD
Ethotoin—SCN4A—Axon guidance—EGFR—ovarian cancer	6.9e-05	0.00168	CbGpPWpGaD
Ethotoin—SCN1A—Developmental Biology—ERBB2—ovarian cancer	6.85e-05	0.00167	CbGpPWpGaD
Ethotoin—SCN10A—Developmental Biology—ERBB2—ovarian cancer	6.85e-05	0.00167	CbGpPWpGaD
Ethotoin—SCN11A—Developmental Biology—KRAS—ovarian cancer	6.84e-05	0.00167	CbGpPWpGaD
Ethotoin—SCN3A—Axon guidance—KRAS—ovarian cancer	6.78e-05	0.00165	CbGpPWpGaD
Ethotoin—SCN9A—Developmental Biology—CTNNB1—ovarian cancer	6.76e-05	0.00165	CbGpPWpGaD
Ethotoin—SCN5A—Axon guidance—ERBB2—ovarian cancer	6.75e-05	0.00164	CbGpPWpGaD
Ethotoin—SCN10A—Axon guidance—MAPK1—ovarian cancer	6.65e-05	0.00162	CbGpPWpGaD
Ethotoin—SCN1A—Axon guidance—MAPK1—ovarian cancer	6.65e-05	0.00162	CbGpPWpGaD
Ethotoin—SCN10A—Axon guidance—EGFR—ovarian cancer	6.65e-05	0.00162	CbGpPWpGaD
Ethotoin—SCN1A—Axon guidance—EGFR—ovarian cancer	6.65e-05	0.00162	CbGpPWpGaD
Ethotoin—SCN9A—Developmental Biology—MMP9—ovarian cancer	6.63e-05	0.00161	CbGpPWpGaD
Ethotoin—SCN8A—Developmental Biology—MAPK1—ovarian cancer	6.63e-05	0.00161	CbGpPWpGaD
Ethotoin—SCN8A—Developmental Biology—EGFR—ovarian cancer	6.62e-05	0.00161	CbGpPWpGaD
Ethotoin—SCN5A—Developmental Biology—MET—ovarian cancer	6.59e-05	0.0016	CbGpPWpGaD
Ethotoin—SCN7A—Developmental Biology—HRAS—ovarian cancer	6.53e-05	0.00159	CbGpPWpGaD
Ethotoin—SCN4A—Axon guidance—KRAS—ovarian cancer	6.52e-05	0.00159	CbGpPWpGaD
Ethotoin—SCN2A—Axon guidance—KRAS—ovarian cancer	6.52e-05	0.00159	CbGpPWpGaD
Ethotoin—SCN3A—Developmental Biology—CTNNB1—ovarian cancer	6.47e-05	0.00158	CbGpPWpGaD
Ethotoin—SCN5A—Developmental Biology—IL6ST—ovarian cancer	6.45e-05	0.00157	CbGpPWpGaD
Ethotoin—SCN5A—SIDS Susceptibility Pathways—IL6—ovarian cancer	6.45e-05	0.00157	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	6.34e-05	0.00154	CbGpPWpGaD
Ethotoin—SCN3A—Developmental Biology—MMP9—ovarian cancer	6.34e-05	0.00154	CbGpPWpGaD
Ethotoin—SCN10A—Axon guidance—KRAS—ovarian cancer	6.28e-05	0.00153	CbGpPWpGaD
Ethotoin—SCN1A—Axon guidance—KRAS—ovarian cancer	6.28e-05	0.00153	CbGpPWpGaD
Ethotoin—SCN8A—Developmental Biology—KRAS—ovarian cancer	6.26e-05	0.00152	CbGpPWpGaD
Ethotoin—SCN7A—Developmental Biology—IL6—ovarian cancer	6.25e-05	0.00152	CbGpPWpGaD
Ethotoin—SCN2A—Developmental Biology—CTNNB1—ovarian cancer	6.21e-05	0.00151	CbGpPWpGaD
Ethotoin—SCN4A—Developmental Biology—CTNNB1—ovarian cancer	6.21e-05	0.00151	CbGpPWpGaD
Ethotoin—SCN2A—Developmental Biology—MMP9—ovarian cancer	6.09e-05	0.00148	CbGpPWpGaD
Ethotoin—SCN4A—Developmental Biology—MMP9—ovarian cancer	6.09e-05	0.00148	CbGpPWpGaD
Ethotoin—SCN9A—Axon guidance—HRAS—ovarian cancer	6.03e-05	0.00147	CbGpPWpGaD
Ethotoin—SCN1A—Developmental Biology—CTNNB1—ovarian cancer	5.99e-05	0.00146	CbGpPWpGaD
Ethotoin—SCN10A—Developmental Biology—CTNNB1—ovarian cancer	5.99e-05	0.00146	CbGpPWpGaD
Ethotoin—SCN9A—Developmental Biology—VEGFA—ovarian cancer	5.95e-05	0.00145	CbGpPWpGaD
Ethotoin—SCN9A—Developmental Biology—STAT3—ovarian cancer	5.89e-05	0.00144	CbGpPWpGaD
Ethotoin—SCN9A—Developmental Biology—NRAS—ovarian cancer	5.88e-05	0.00143	CbGpPWpGaD
Ethotoin—SCN10A—Developmental Biology—MMP9—ovarian cancer	5.87e-05	0.00143	CbGpPWpGaD
Ethotoin—SCN1A—Developmental Biology—MMP9—ovarian cancer	5.87e-05	0.00143	CbGpPWpGaD
Ethotoin—SCN11A—Developmental Biology—HRAS—ovarian cancer	5.82e-05	0.00142	CbGpPWpGaD
Ethotoin—SCN5A—Axon guidance—MMP9—ovarian cancer	5.79e-05	0.00141	CbGpPWpGaD
Ethotoin—SCN9A—Axon guidance—IL6—ovarian cancer	5.77e-05	0.00141	CbGpPWpGaD
Ethotoin—SCN3A—Axon guidance—HRAS—ovarian cancer	5.77e-05	0.0014	CbGpPWpGaD
Ethotoin—SCN7A—Developmental Biology—AKT1—ovarian cancer	5.76e-05	0.0014	CbGpPWpGaD
Ethotoin—SCN3A—Developmental Biology—VEGFA—ovarian cancer	5.69e-05	0.00139	CbGpPWpGaD
Ethotoin—SCN3A—Developmental Biology—STAT3—ovarian cancer	5.64e-05	0.00137	CbGpPWpGaD
Ethotoin—SCN9A—Developmental Biology—MAPK3—ovarian cancer	5.63e-05	0.00137	CbGpPWpGaD
Ethotoin—SCN3A—Developmental Biology—NRAS—ovarian cancer	5.62e-05	0.00137	CbGpPWpGaD
Ethotoin—SCN11A—Developmental Biology—IL6—ovarian cancer	5.57e-05	0.00136	CbGpPWpGaD
Ethotoin—SCN2A—Axon guidance—HRAS—ovarian cancer	5.54e-05	0.00135	CbGpPWpGaD
Ethotoin—SCN4A—Axon guidance—HRAS—ovarian cancer	5.54e-05	0.00135	CbGpPWpGaD
Ethotoin—SCN3A—Axon guidance—IL6—ovarian cancer	5.52e-05	0.00134	CbGpPWpGaD
Ethotoin—SCN5A—Developmental Biology—MMP2—ovarian cancer	5.49e-05	0.00134	CbGpPWpGaD
Ethotoin—SCN2A—Developmental Biology—VEGFA—ovarian cancer	5.47e-05	0.00133	CbGpPWpGaD
Ethotoin—SCN4A—Developmental Biology—VEGFA—ovarian cancer	5.47e-05	0.00133	CbGpPWpGaD
Ethotoin—SCN2A—Developmental Biology—STAT3—ovarian cancer	5.42e-05	0.00132	CbGpPWpGaD
Ethotoin—SCN4A—Developmental Biology—STAT3—ovarian cancer	5.42e-05	0.00132	CbGpPWpGaD
Ethotoin—SCN4A—Developmental Biology—NRAS—ovarian cancer	5.4e-05	0.00132	CbGpPWpGaD
Ethotoin—SCN2A—Developmental Biology—NRAS—ovarian cancer	5.4e-05	0.00132	CbGpPWpGaD
Ethotoin—SCN3A—Developmental Biology—MAPK3—ovarian cancer	5.39e-05	0.00131	CbGpPWpGaD
Ethotoin—SCN9A—Developmental Biology—MAPK1—ovarian cancer	5.36e-05	0.0013	CbGpPWpGaD
Ethotoin—SCN9A—Developmental Biology—EGFR—ovarian cancer	5.36e-05	0.0013	CbGpPWpGaD
Ethotoin—SCN1A—Axon guidance—HRAS—ovarian cancer	5.34e-05	0.0013	CbGpPWpGaD
Ethotoin—SCN10A—Axon guidance—HRAS—ovarian cancer	5.34e-05	0.0013	CbGpPWpGaD
Ethotoin—SCN8A—Developmental Biology—HRAS—ovarian cancer	5.32e-05	0.0013	CbGpPWpGaD
Ethotoin—SCN2A—Axon guidance—IL6—ovarian cancer	5.3e-05	0.00129	CbGpPWpGaD
Ethotoin—SCN4A—Axon guidance—IL6—ovarian cancer	5.3e-05	0.00129	CbGpPWpGaD
Ethotoin—SCN1A—Developmental Biology—VEGFA—ovarian cancer	5.28e-05	0.00128	CbGpPWpGaD
Ethotoin—SCN10A—Developmental Biology—VEGFA—ovarian cancer	5.28e-05	0.00128	CbGpPWpGaD
Ethotoin—SCN1A—Developmental Biology—STAT3—ovarian cancer	5.22e-05	0.00127	CbGpPWpGaD
Ethotoin—SCN10A—Developmental Biology—STAT3—ovarian cancer	5.22e-05	0.00127	CbGpPWpGaD
Ethotoin—SCN10A—Developmental Biology—NRAS—ovarian cancer	5.21e-05	0.00127	CbGpPWpGaD
Ethotoin—SCN1A—Developmental Biology—NRAS—ovarian cancer	5.21e-05	0.00127	CbGpPWpGaD
Ethotoin—SCN5A—Axon guidance—VEGFA—ovarian cancer	5.2e-05	0.00127	CbGpPWpGaD
Ethotoin—SCN4A—Developmental Biology—MAPK3—ovarian cancer	5.18e-05	0.00126	CbGpPWpGaD
Ethotoin—SCN2A—Developmental Biology—MAPK3—ovarian cancer	5.18e-05	0.00126	CbGpPWpGaD
Ethotoin—SCN11A—Developmental Biology—AKT1—ovarian cancer	5.14e-05	0.00125	CbGpPWpGaD
Ethotoin—SCN5A—Axon guidance—NRAS—ovarian cancer	5.13e-05	0.00125	CbGpPWpGaD
Ethotoin—SCN3A—Developmental Biology—MAPK1—ovarian cancer	5.13e-05	0.00125	CbGpPWpGaD
Ethotoin—SCN3A—Developmental Biology—EGFR—ovarian cancer	5.12e-05	0.00125	CbGpPWpGaD
Ethotoin—SCN1A—Axon guidance—IL6—ovarian cancer	5.11e-05	0.00125	CbGpPWpGaD
Ethotoin—SCN10A—Axon guidance—IL6—ovarian cancer	5.11e-05	0.00125	CbGpPWpGaD
Ethotoin—SCN8A—Developmental Biology—IL6—ovarian cancer	5.09e-05	0.00124	CbGpPWpGaD
Ethotoin—SCN9A—Developmental Biology—KRAS—ovarian cancer	5.06e-05	0.00123	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—NME2—ovarian cancer	5.02e-05	0.00122	CbGpPWpGaD
Ethotoin—SCN10A—Developmental Biology—MAPK3—ovarian cancer	4.99e-05	0.00122	CbGpPWpGaD
Ethotoin—SCN1A—Developmental Biology—MAPK3—ovarian cancer	4.99e-05	0.00122	CbGpPWpGaD
Ethotoin—SCN4A—Developmental Biology—MAPK1—ovarian cancer	4.92e-05	0.0012	CbGpPWpGaD
Ethotoin—SCN2A—Developmental Biology—MAPK1—ovarian cancer	4.92e-05	0.0012	CbGpPWpGaD
Ethotoin—SCN2A—Developmental Biology—EGFR—ovarian cancer	4.92e-05	0.0012	CbGpPWpGaD
Ethotoin—SCN4A—Developmental Biology—EGFR—ovarian cancer	4.92e-05	0.0012	CbGpPWpGaD
Ethotoin—SCN5A—Axon guidance—MAPK3—ovarian cancer	4.92e-05	0.0012	CbGpPWpGaD
Ethotoin—SCN3A—Developmental Biology—KRAS—ovarian cancer	4.84e-05	0.00118	CbGpPWpGaD
Ethotoin—SCN5A—Developmental Biology—ERBB2—ovarian cancer	4.81e-05	0.00117	CbGpPWpGaD
Ethotoin—SCN1A—Developmental Biology—MAPK1—ovarian cancer	4.75e-05	0.00116	CbGpPWpGaD
Ethotoin—SCN10A—Developmental Biology—MAPK1—ovarian cancer	4.75e-05	0.00116	CbGpPWpGaD
Ethotoin—SCN1A—Developmental Biology—EGFR—ovarian cancer	4.75e-05	0.00116	CbGpPWpGaD
Ethotoin—SCN10A—Developmental Biology—EGFR—ovarian cancer	4.75e-05	0.00116	CbGpPWpGaD
Ethotoin—SCN8A—Developmental Biology—AKT1—ovarian cancer	4.7e-05	0.00114	CbGpPWpGaD
Ethotoin—SCN5A—Axon guidance—MAPK1—ovarian cancer	4.68e-05	0.00114	CbGpPWpGaD
Ethotoin—SCN5A—Axon guidance—EGFR—ovarian cancer	4.68e-05	0.00114	CbGpPWpGaD
Ethotoin—SCN2A—Developmental Biology—KRAS—ovarian cancer	4.65e-05	0.00113	CbGpPWpGaD
Ethotoin—SCN4A—Developmental Biology—KRAS—ovarian cancer	4.65e-05	0.00113	CbGpPWpGaD
Ethotoin—SCN10A—Developmental Biology—KRAS—ovarian cancer	4.48e-05	0.00109	CbGpPWpGaD
Ethotoin—SCN1A—Developmental Biology—KRAS—ovarian cancer	4.48e-05	0.00109	CbGpPWpGaD
Ethotoin—SCN5A—Axon guidance—KRAS—ovarian cancer	4.42e-05	0.00108	CbGpPWpGaD
Ethotoin—SCN9A—Developmental Biology—HRAS—ovarian cancer	4.3e-05	0.00105	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	4.25e-05	0.00104	CbGpPWpGaD
Ethotoin—SCN5A—Developmental Biology—CTNNB1—ovarian cancer	4.21e-05	0.00103	CbGpPWpGaD
Ethotoin—SCN5A—Developmental Biology—MMP9—ovarian cancer	4.13e-05	0.00101	CbGpPWpGaD
Ethotoin—SCN9A—Developmental Biology—IL6—ovarian cancer	4.12e-05	0.001	CbGpPWpGaD
Ethotoin—SCN3A—Developmental Biology—HRAS—ovarian cancer	4.11e-05	0.001	CbGpPWpGaD
Ethotoin—SCN2A—Developmental Biology—HRAS—ovarian cancer	3.95e-05	0.000963	CbGpPWpGaD
Ethotoin—SCN4A—Developmental Biology—HRAS—ovarian cancer	3.95e-05	0.000963	CbGpPWpGaD
Ethotoin—SCN3A—Developmental Biology—IL6—ovarian cancer	3.94e-05	0.000959	CbGpPWpGaD
Ethotoin—SCN10A—Developmental Biology—HRAS—ovarian cancer	3.81e-05	0.000928	CbGpPWpGaD
Ethotoin—SCN1A—Developmental Biology—HRAS—ovarian cancer	3.81e-05	0.000928	CbGpPWpGaD
Ethotoin—SCN9A—Developmental Biology—AKT1—ovarian cancer	3.8e-05	0.000925	CbGpPWpGaD
Ethotoin—SCN2A—Developmental Biology—IL6—ovarian cancer	3.78e-05	0.000921	CbGpPWpGaD
Ethotoin—SCN4A—Developmental Biology—IL6—ovarian cancer	3.78e-05	0.000921	CbGpPWpGaD
Ethotoin—SCN5A—Axon guidance—HRAS—ovarian cancer	3.76e-05	0.000915	CbGpPWpGaD
Ethotoin—SCN5A—Developmental Biology—VEGFA—ovarian cancer	3.71e-05	0.000903	CbGpPWpGaD
Ethotoin—SCN5A—Developmental Biology—STAT3—ovarian cancer	3.67e-05	0.000894	CbGpPWpGaD
Ethotoin—SCN5A—Developmental Biology—NRAS—ovarian cancer	3.66e-05	0.000892	CbGpPWpGaD
Ethotoin—SCN1A—Developmental Biology—IL6—ovarian cancer	3.65e-05	0.000888	CbGpPWpGaD
Ethotoin—SCN10A—Developmental Biology—IL6—ovarian cancer	3.65e-05	0.000888	CbGpPWpGaD
Ethotoin—SCN3A—Developmental Biology—AKT1—ovarian cancer	3.63e-05	0.000885	CbGpPWpGaD
Ethotoin—SCN5A—Axon guidance—IL6—ovarian cancer	3.59e-05	0.000875	CbGpPWpGaD
Ethotoin—SCN5A—Developmental Biology—MAPK3—ovarian cancer	3.51e-05	0.000854	CbGpPWpGaD
Ethotoin—SCN2A—Developmental Biology—AKT1—ovarian cancer	3.49e-05	0.00085	CbGpPWpGaD
Ethotoin—SCN4A—Developmental Biology—AKT1—ovarian cancer	3.49e-05	0.00085	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	3.47e-05	0.000845	CbGpPWpGaD
Ethotoin—SCN10A—Developmental Biology—AKT1—ovarian cancer	3.37e-05	0.00082	CbGpPWpGaD
Ethotoin—SCN1A—Developmental Biology—AKT1—ovarian cancer	3.37e-05	0.00082	CbGpPWpGaD
Ethotoin—SCN5A—Developmental Biology—MAPK1—ovarian cancer	3.34e-05	0.000813	CbGpPWpGaD
Ethotoin—SCN5A—Developmental Biology—EGFR—ovarian cancer	3.34e-05	0.000813	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—CYTB—ovarian cancer	3.23e-05	0.000787	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	3.16e-05	0.000769	CbGpPWpGaD
Ethotoin—SCN5A—Developmental Biology—KRAS—ovarian cancer	3.15e-05	0.000768	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—PPP1CC—ovarian cancer	2.82e-05	0.000688	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—BRIP1—ovarian cancer	2.82e-05	0.000688	CbGpPWpGaD
Ethotoin—SCN5A—Developmental Biology—HRAS—ovarian cancer	2.68e-05	0.000653	CbGpPWpGaD
Ethotoin—SCN5A—Developmental Biology—IL6—ovarian cancer	2.56e-05	0.000625	CbGpPWpGaD
Ethotoin—SCN5A—Developmental Biology—AKT1—ovarian cancer	2.37e-05	0.000576	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	2.06e-05	0.000501	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—YAP1—ovarian cancer	1.89e-05	0.000461	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	1.88e-05	0.000457	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	1.65e-05	0.000401	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—FASN—ovarian cancer	1.54e-05	0.000376	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—SLC5A5—ovarian cancer	1.52e-05	0.00037	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—SLC2A1—ovarian cancer	1.47e-05	0.000357	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	1.44e-05	0.00035	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—CYP1B1—ovarian cancer	1.41e-05	0.000343	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—PPP2R1A—ovarian cancer	1.25e-05	0.000304	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	1.24e-05	0.000302	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—ABCB1—ovarian cancer	1.16e-05	0.000282	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—TYMS—ovarian cancer	1.14e-05	0.000277	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—CAV1—ovarian cancer	9.17e-06	0.000223	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	8.76e-06	0.000213	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—PIK3CG—ovarian cancer	8.35e-06	0.000203	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—PIK3CD—ovarian cancer	7.34e-06	0.000179	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—PIK3CB—ovarian cancer	6.4e-06	0.000156	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—PTEN—ovarian cancer	5.53e-06	0.000135	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—PIK3CA—ovarian cancer	3.9e-06	9.5e-05	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—AKT1—ovarian cancer	3.19e-06	7.76e-05	CbGpPWpGaD
